Article
Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer's and Lewy body neuropathology.
Alzheimer's research & therapy - 23 Jan 2021
Pillai Jagan A, Bena James, Bonner-Jackson Aaron, Leverenz James B
Abstract excerpt
BACKGROUND: APOE ε4 carrier status is known to increase odds of amnestic presentations with Alzheimer's pathology. It is unknown how APOE ε4 carrier status impacts odds of specific initial cognitive symptoms in the presence of Lewy body pathology. Here we evaluate the impact of APOE ε4 genotype on initial cognitive symptoms among those with Alzheimer's disease pathology (ADP) and Lewy-related pathology (LRP)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
